Universal Health Realty Income Trust (UHT)
—Data provided by IEX. Delayed 15 minutes.
Explore Other Stocks In...
Valuation Measures
Financial Highlights
Balance Sheet Strength
Similar Companies
Company Profile
Price Chart
Loading chart...
At a glance
• The UHS relationship is both UHT's moat and its Achilles' heel: While the 40-year affiliation with Universal Health Services (UHS) provides preferred access to hospital developments and stable lease renewals, it also concentrates 40% of revenues with a single operator, creating risk if UHS faces financial distress or chooses not to renew leases upon expiration in 2026-2027.
• Dividend sustainability requires monitoring: The 7.49% dividend yield is supported by operating cash flows of $49.1M, which covered the $36.8M in dividend distributions in 2025. However, the high payout ratio relative to net income suggests that FFO growth or capital management will be necessary to maintain this level without increasing leverage.
• Small scale provides stability but limits expansion: With 77 properties and $99.2M in annual revenue, UHT is smaller than Welltower (WELL) or Ventas (VTR) . This niche positioning offers defensive characteristics through essential healthcare facilities but constrains acquisition firepower, resulting in flat revenue growth of 0.2% in 2025 while larger peers expand.
• Interest rate headwinds are moderating: The company swapped $85 million of variable-rate debt in October 2024 at fixed rates, contributing to a $2.7M increase in interest expense in 2025. With a 43.6% total leverage ratio, UHT remains sensitive to rate movements, with a 1% shift impacting net income by $1.9M.
• Legislative changes affect tenant environments: The July 2025 "One Big Beautiful Bill Act" aims to reduce Medicaid enrollment and adjust provider fees, potentially pressuring the margins of UHS and other tenants. Combined with the expiration of certain tax credits, this creates a multi-year headwind for healthcare operators.
Growth Outlook
Profitability
Competitive Moat
Financial Health
Valuation
Returns to Shareholders
Financial Charts
Financial Performance
Profitability Margins
Earnings Performance
Cash Flow Generation
Return Metrics
Balance Sheet Health
Shareholder Returns
Valuation Metrics
Financial data will be displayed here
Valuation Ratios
Profitability Ratios
Liquidity Ratios
Leverage Ratios
Cash Flow Ratios
Capital Allocation
Advanced Valuation
Efficiency Ratios
UHT's UHS Dependency: A Defensive Healthcare REIT Yielding 7.5% With a Concentration Problem (NYSE:UHT)
Executive Summary / Key Takeaways
-
The UHS relationship is both UHT's moat and its Achilles' heel: While the 40-year affiliation with Universal Health Services (UHS) provides preferred access to hospital developments and stable lease renewals, it also concentrates 40% of revenues with a single operator, creating risk if UHS faces financial distress or chooses not to renew leases upon expiration in 2026-2027.
-
Dividend sustainability requires monitoring: The 7.49% dividend yield is supported by operating cash flows of $49.1M, which covered the $36.8M in dividend distributions in 2025. However, the high payout ratio relative to net income suggests that FFO growth or capital management will be necessary to maintain this level without increasing leverage.
-
Small scale provides stability but limits expansion: With 77 properties and $99.2M in annual revenue, UHT is smaller than Welltower (WELL) or Ventas (VTR). This niche positioning offers defensive characteristics through essential healthcare facilities but constrains acquisition firepower, resulting in flat revenue growth of 0.2% in 2025 while larger peers expand.
-
Interest rate headwinds are moderating: The company swapped $85 million of variable-rate debt in October 2024 at fixed rates, contributing to a $2.7M increase in interest expense in 2025. With a 43.6% total leverage ratio, UHT remains sensitive to rate movements, with a 1% shift impacting net income by $1.9M.
-
Legislative changes affect tenant environments: The July 2025 "One Big Beautiful Bill Act" aims to reduce Medicaid enrollment and adjust provider fees, potentially pressuring the margins of UHS and other tenants. Combined with the expiration of certain tax credits, this creates a multi-year headwind for healthcare operators.
Setting the Scene: The Hospital REIT With a Built-In Tenant
Universal Health Realty Income Trust, founded in 1986 as a Maryland REIT, operates as a landlord to healthcare operators where its largest tenant is also its corporate sponsor. Chairman and CEO Alan B. Miller has led both UHT and Universal Health Services since inception, creating a relationship where UHT acquires properties from UHS subsidiaries and leases them back under long-term agreements. This structure, formalized through an advisory agreement, means UHT’s investment pipeline often flows from UHS's operational needs.
The company generates revenue through triple-net leases on seventy-seven healthcare facilities across twenty-one states. The portfolio is split between hospital facilities and medical office buildings (MOBs), with UHS subsidiaries leasing six hospitals and nineteen MOBs while non-affiliated tenants occupy the remainder. This model provides base rents with potential upside from bonus rents tied to hospital performance.
The significance of this structure lies in the captive development pipeline. When UHS expands, UHT often receives the first opportunity to acquire the real estate. However, this also concentrates risk: UHS-related tenants contributed 40% of consolidated revenue in 2025. While peers like Welltower and Ventas maintain hundreds of tenants, UHT's performance is closely tied to UHS's strategic priorities.
The healthcare real estate landscape has shifted toward senior housing and outpatient facilities, yet UHT's portfolio remains anchored to inpatient hospitals and MOBs. This provides defensive characteristics, as emergency care and surgeries are essential services, though it results in slower growth compared to segments where Welltower is more active. UHT's strategy prioritizes stability over rapid scale.
Technology, Products, and Strategic Differentiation: The UHS Moat and Triple-Net Simplicity
UHT's competitive advantage stems from its relationship with UHS and its disciplined triple-net lease structure. The advisory agreement ensures UHT pays UHS fees for management services, aligning incentives as UHS has a motivation to maintain its leased properties.
The triple-net lease model passes property expenses—taxes, insurance, and maintenance—to tenants, yielding high gross margins. For occupied hospital facilities, UHT collected $21.91 per square foot in 2025, up from $21.55 in 2024. MOBs and childcare centers generated $34.51 per square foot, a 2.3% increase. These escalations provide inflation protection and demonstrate pricing power in essential healthcare facilities.
This creates a high-margin business that performs best in stable environments. However, growth requires acquisitions, and UHT's scale means each deal has a modest impact. The $7.6M McAllen Doctors Center acquisition in Q3 2023 added to the asset base, while the $3.9M Corpus Christi divestiture in December 2023 resulted in a small loss. These transactions show UHT can recycle capital but lacks the firepower for transformative deals that would diversify the portfolio away from UHS.
Sustainability initiatives demonstrate operational discipline. LED retrofits and energy management systems reduce operating costs for tenants. More significantly, UHT added environmental clauses to standard leases, requiring tenant cooperation on sustainability plans. This positions UHT favorably regarding long-term building efficiency and evolving building codes.
Financial Performance & Segment Dynamics: Flat Growth, Stable Cash Flows
Financial results for 2025 show a company maintaining its position. Revenue increased $179K (0.2%) to $99.19M, with a boost in bonus rents offset by a revenue drop at an Amarillo MOB vacated in Q4. Net income was $17.6M, impacted by nonrecurring depreciation and the absence of a prior-year property tax reduction. Funds From Operations (FFO) was $47.69M.
Segment performance shows divergent trends. UHS facility lease revenue was $33.4M in 2025, with bonus rents up 11.6% to $3.5M. The McAllen Medical Center bonus rent grew to $3.5M in 2025, demonstrating hospital tenant strength. Non-related party lease revenue rose slightly to $57.7M, with base rents up 0.9% but tenant reimbursements down 2.4%, indicating some pressure on expense pass-throughs.
The lack of significant organic growth highlights the importance of the acquisition pipeline. While rental rate increases on lease renewals averaged 3%, tenant improvement costs rose to $16 per square foot in 2025 from $7 in 2024. This suggests UHT is investing more into its properties to retain tenants.
Cash flow generation remains a core strength. Operating cash flow was $49.1M in 2025, which covers the $36.8M in dividend payments. The $425M credit facility provides $68.8M of available capacity as of December 31, 2025. With $347.6M drawn and average borrowing costs at 5.85%, the company manages its debt levels relative to its size.
Balance sheet metrics show a total leverage of 43.6%, which is within covenant limits. The debt-to-equity ratio of 2.53x is higher than larger peers like Welltower, reflecting UHT's smaller equity base. The enterprise value of $929.96M compared to a $552.21M market cap indicates the role of debt in the capital structure.
Outlook, Management Guidance, and Execution Risk
Management indicates that operating cash flows have been sufficient to fund dividends and that available capital resources are expected to meet requirements for the next twelve months. Future dividend levels will be determined by REIT distribution requirements and projected operating results.
The strategic focus remains on targeted developments. Construction began in February 2026 on Palm Beach Gardens Medical Plaza I, an 80,000 square foot MOB costing $34M, with a UHS subsidiary master-leasing 75% of the space for ten years. This investment represents a significant commitment to the UHS relationship. Expected completion in Q4 2026 will add to stabilized cash flow in 2027.
Sierra Medical Plaza I in Reno has cost $30M through December 2025 and will provide incremental revenue as leasing progresses. These developments show UHT can execute projects, though the pace is measured. A key factor for the 2026-2027 period will be the renewal of hospital leases, which represent a significant portion of annual revenue.
The significance of these expirations lies in the potential for a valuation re-rating. If UHS renews, concentration risk concerns may ease. If UHS exercises purchase options or vacates, UHT would need to redeploy capital or re-lease the space. Certain properties, like Aiken Regional and Canyon Creek, are already treated as financing arrangements due to UHS purchase options, contributing interest income rather than lease revenue.
Risks and Asymmetries: Where the Story Breaks
Concentration risk is the primary factor for the company. With 40% of revenue from UHS, any financial pressure on the tenant would impact UHT. The "One Big Beautiful Bill Act" could reduce Medicaid provider fees, pressuring hospital margins. If leases are not renewed, UHT must find new tenants or sell properties. The vacant Evansville specialty facility, which has incurred operating expenses since 2019, illustrates the cost of unleased assets.
Interest rate risk is also a factor. A 1% rate increase would impact net income by $1.9M based on variable-rate debt levels. While the October 2024 swap locked in fixed rates, further draws on the credit facility would increase sensitivity to market rates. UHT's smaller size compared to Ventas or Welltower can result in different debt terms.
Legislative changes regarding Medicaid and the expiration of ACA premium tax credits could increase uncompensated care for hospital tenants. While the triple-net structure protects UHT from direct operating cost increases, tenant financial health is critical for long-term rent collection and property valuations.
Competitive Context and Positioning: Small Fish, Stable Pond
UHT's competitive position is defined by its niche focus. Welltower and Ventas have significantly larger market caps and revenue bases, with Welltower seeing growth in senior housing—a segment UHT does not prioritize.
This size difference means UHT focuses on smaller, strategic developments rather than large portfolio acquisitions. However, UHT's 94.45% gross margin is high because its triple-net structure and UHS relationship minimize direct operating expenses.
Among comparable peers, Omega Healthcare Investors (OHI) focuses on skilled nursing facilities. While OHI has a high gross margin, it faces different reimbursement risks. National Health Investors (NHI) trades at a similar revenue multiple to UHT, and like UHT, manages dividend levels relative to cash flow.
UHT's primary differentiator is its integration with UHS. While other REITs compete for operators on the open market, UHT has a direct line to UHS developments. This reduces tenant acquisition costs, though it also means UHT's growth is linked to UHS's expansion pace.
Valuation Context: Yield and Sustainability
At $39.80 per share, UHT trades at 11.25x operating cash flow. The 7.49% dividend yield is supported by $49.1M in operating cash flow against $36.8M in distributions. The enterprise value of $929.96M represents 9.38x revenue, which is a discount to OHI but comparable to other healthcare REITs.
The valuation suggests the market is monitoring the upcoming UHS lease renewals. The debt-to-equity ratio of 2.53x is a factor in the risk premium assigned to the stock. If cash flow were to deteriorate due to lease expirations, the dividend coverage would tighten.
Comparing to OHI and NHI, UHT’s yield is higher, reflecting its specific concentration risk. Management has noted that operating cash flows have been sufficient to cover dividends, but the margin for error is narrower than in previous years. The $100M shelf registration filed in April 2024 provides a mechanism for raising equity if needed for growth or balance sheet management. The key for valuation is whether FFO can grow as new developments like Palm Beach Gardens come online.
Conclusion: A Defensive REIT at an Inflection Point
Universal Health Realty Income Trust provides a focused investment in healthcare real estate with a strategic relationship that offers both stability and concentration. The 7.49% dividend yield is currently covered by operating cash flow, but long-term sustainability depends on operational growth and the 2026-2027 lease renewals with UHS.
The investment outlook depends on whether UHS renews its hospital leases and whether UHT can successfully integrate new developments like the $34M Palm Beach Gardens project. Success in these areas would likely support the current valuation. UHT's small scale and concentration require a higher risk premium, but its defensive portfolio provides a level of protection. Investors should monitor the trajectory of FFO and lease renewal announcements through 2026 to assess the stability of the income stream.
If you're interested in this stock, you can get curated updates by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.
Disclaimer: This report is for informational purposes only and does not constitute financial advice, investment advice, or any other type of advice. The information provided should not be relied upon for making investment decisions. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.
Loading latest news...
No recent news catalysts found for UHT.
Market activity may be driven by other factors.
Want updates like this for other stocks you follow?
You only receive important, fundamentals-focused updates for stocks you subscribe to.
Subscribe to updates for: